MCO-010, an optogenetic therapy, demonstrated long-term safety and improved quality of life in patients with retinitis ...

We report a case of posterior lens nucleus displacement following an intravitreal injection of bevacizumab (IVB). To the best of our knowledge this complication has not been previously reported. A ...

This study reviewed 15,895 intravitreal injections (9453 ranibizumab, 5386 bevacizumab, 935 triamcinolone, and 121 pegaptanib) that were performed for various indications over a 5-year period. Of the ...

After announcing earlier this week the appointment of Andreas Wallnöfer, PhD, MBA, to its Board of Directors, Optigo ...

Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a five-year follow-up of participants who received a single intravitreal injection of MCO-010 in an ...

Please provide your email address to receive an email when new articles are posted on . I believe intravitreal injections are best performed in the office for many reasons. First of all, it is safe.

Only 30 cases of endophthalmitis occurred after 90,339 intravitreal injections, and prophylactic antibiotics did not decrease the rate of infections, a recent study suggests. Most physicians no longer ...

D Molecular Therapeutics, Inc. (($FDMT)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase ...

Patients maintained a consistent and clinically meaningful reduction in supplemental injections in 6-month intervals following dosing with 4D-150, supporting durable disease control across all ...

A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...